性别与性别因素在肺疾病和睡眠障碍中的最新综述
该综述汇总了性别(生物学)与性别(社会)因素对多种肺疾病和睡眠障碍的影响。女性哮喘更常见,淋巴管肌瘤病几乎仅见于女性;COPD女性急性加重次数更多,睡眠呼吸障碍女性心血管并发症更高。治疗反应和用药安全也存在性别差异,但临床试验常未充分纳入药物基因组学因素。
要点
- 女性哮喘患病率更高,淋巴管肌瘤病几乎仅见于女性。
- COPD女性急性加重次数更多,睡眠呼吸障碍女性心血管并发症更高。
- 药物反应和安全性存在性别差异,但临床试验常未充分评估。
核心结论
- 性别与性别因素影响肺疾病和睡眠障碍的发病率、易感性、表现、诊断及严重程度。
- 理解这些差异是实现女性精准医学的第一步。
研究设计与样本
- 本文为最新综述,回顾文献并聚焦近期关于研究中性别与性别因素使用的指南。
- 综述范围包括流行病学、疾病表现、危险因素和管理,病理生物学机制不在本文范围内。
主要发现
- 哮喘在女性中更常见,淋巴管肌瘤病几乎仅见于女性。
- COPD女性急性加重次数更多,睡眠呼吸障碍女性心血管并发症更高。
- 治疗反应和用药安全可能因性别而异,但药物基因组学因素在临床试验中常未被充分处理。
关键数值与推荐
- 女性哮喘更常见;淋巴管肌瘤病几乎仅见于女性。
- COPD女性急性加重次数更多;睡眠呼吸障碍女性心血管并发症更高。
临床怎么用
- 临床应关注肺疾病和睡眠障碍的性别差异,在诊断和管理中考虑性别因素。
- 治疗选择和用药安全评估需考虑性别差异及药物基因组学因素。
局限性
- 病理生物学机制解释性别差异不在本文范围内。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The terms sex and gender often are used interchangeably, but have specific meaning when it comes to their effects on lung disease. Ample evidence is now available that sex and gender affect the incidence, susceptibility, presentation, diagnosis, and severity of many lung diseases. Some conditions are more prevalent in women, such as asthma. Other conditions are seen almost exclusively in women, like lymphangioleiomyomatosis. Some life stages-such as pregnancy-are unique to women and can affect the onset and course of lung disease. Clinical presentation may differ as well, such as higher number of exacerbations experienced by women with COPD and greater cardiovascular morbidity in women with sleep-disordered breathing. In addition, response to therapy and medication safety may also differ by sex, and yet, pharmacogenomic factors often are not addressed adequately in clinical trials. Various aspects of lung and sleep biology and pathobiology are impacted by female sex and female reproductive transitions. Differential gene expression or organ development can be impacted by these biological differences. Understanding these differences is the first step in moving toward precision medicine for women. This article is a state-of-the-art review of specific effects of sex and gender focused on epidemiology, disease presentation, risk factors, and management of lung diseases. Pathobiological mechanisms explaining sex differences in these diseases are beyond the scope of this article. We review the literature and focus on recent guidelines about using sex and gender in research. We also review sex and gender differences in lung diseases.
引用
- Sodhi A, Pisani M, Glassberg MK, et al. Sex and Gender in Lung Disease and Sleep Disorders: A State-of-the-Art Review. Chest. 2022. PMID: 35300976. doi:10.1016/j.chest.2022.03.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。